BAPN, a potent inhibitor of Lysyl-oxidase (LOX), increases the risk of both AD and AAA [26], accompanied by histological signs such as elastic fiber breaks, thrombus formation, and leukocyte infiltration [27]. This evidence concerns the gene LOX and triple-A syndrome.